158 related articles for article (PubMed ID: 36476606)
1. Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis.
Zhu P; Liu G; Wang X; Lu J; Zhou Y; Chen S; Gao Y; Wang C; Yu J; Sun Y; Zhou P
BMC Cancer; 2022 Dec; 22(1):1283. PubMed ID: 36476606
[TBL] [Abstract][Full Text] [Related]
2. GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancer.
Zeng K; Ju G; Wang H; Huang J
Transl Cancer Res; 2020 Apr; 9(4):2363-2377. PubMed ID: 35117597
[TBL] [Abstract][Full Text] [Related]
3. SIRT5 is involved in the proliferation and metastasis of breast cancer by promoting aerobic glycolysis.
He S; Jia Q; Zhou L; Wang Z; Li M
Pathol Res Pract; 2022 Jul; 235():153943. PubMed ID: 35576836
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Expression of
Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
[TBL] [Abstract][Full Text] [Related]
5. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.
Krzeslak A; Wojcik-Krowiranda K; Forma E; Jozwiak P; Romanowicz H; Bienkiewicz A; Brys M
Pathol Oncol Res; 2012 Jul; 18(3):721-8. PubMed ID: 22270867
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
7. Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1.
He Y; Deng F; Zhao S; Zhong S; Zhao J; Wang D; Chen X; Zhang J; Hou J; Zhang W; Ding L; Tang J; Zhou Z
Epigenomics; 2019 Jul; 11(9):1021-1036. PubMed ID: 31184216
[No Abstract] [Full Text] [Related]
8. Immunohistochemical Expression of Melatonin Receptor MT1 and Glucose Transporter GLUT1 in Human Breast Cancer.
de Castro TB; Mota AL; Bordin-Junior NA; Neto DS; Zuccari DAPC
Anticancer Agents Med Chem; 2018; 18(15):2110-2116. PubMed ID: 30360728
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
10. Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.
Xu M; Liu C; Pu L; Lai J; Li J; Ning Q; Liu X; Deng S
Exp Biol Med (Maywood); 2021 Aug; 246(15):1706-1720. PubMed ID: 33899544
[TBL] [Abstract][Full Text] [Related]
11. N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma.
Ma J; Liu W; Guo H; Li S; Cao W; Du X; Lei S; Hou W; Xiong L; Yao L; Li N; Li Y
Breast Cancer Res; 2014 Mar; 16(2):R27. PubMed ID: 24636131
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma.
Hanbazazh M; Samman A; Samargandy S; Al-Maghrabi J
Libyan J Med; 2023 Dec; 18(1):2283953. PubMed ID: 37988377
[TBL] [Abstract][Full Text] [Related]
13. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
[TBL] [Abstract][Full Text] [Related]
15. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT; Liu J; Li GW; Shen JX; Huang YT
Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
17. LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells.
Li Y; Li H; Wang W; Yu X; Xu Q
Mol Cell Probes; 2020 Dec; 54():101667. PubMed ID: 32946972
[TBL] [Abstract][Full Text] [Related]
18. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
[TBL] [Abstract][Full Text] [Related]
19. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK.
Schmidt M; Voelker HU; Kapp M; Krockenberger M; Dietl J; Kammerer U
J Cancer Res Clin Oncol; 2010 Feb; 136(2):219-25. PubMed ID: 19655166
[TBL] [Abstract][Full Text] [Related]
20. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
